Related Experiment Video
Updated: Jul 24, 2025

05:49
Protein Engineering by Yeast Surface Display
Published on: November 29, 2024
1.5K
Accessing Transient Binding Pockets by Protein Engineering and Yeast Surface Display Screening
Jorge A Lerma Romero1, Harald Kolmar2,3
1Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|July 5, 2023
Summary
Researchers engineered a target protein to create a stable binding pocket, overcoming challenges in drug discovery. This method improves ligand screening for previously inaccessible therapeutic targets.
Area of Science:
- Biochemistry
- Structural Biology
- Drug Discovery
Background:
- Therapeutic target binding pockets can adopt multiple conformations influenced by protein dynamics and molecular interactions.
- Inaccessible binding pockets present significant hurdles for identifying and optimizing small-molecule ligands.
- Developing methods to access these cryptic sites is crucial for advancing drug discovery.
Purpose of the Study:
- To engineer target proteins with stable, accessible binding pockets for improved ligand interactions.
- To develop a robust screening strategy for identifying protein variants with enhanced binding capabilities.
- To facilitate the discovery of novel therapeutics targeting previously intractable sites.
Main Methods:
- Protein engineering of a target protein to stabilize its binding pocket.
- Yeast display and fluorescence-activated cell sorting (FACS) for high-throughput screening.
- Selection of protein variants exhibiting improved binding affinity for a cryptic site-specific ligand.
Main Results:
- Successful engineering of protein variants with a stable, transient binding pocket.
- Identification of variants with significantly improved binding for a specific ligand.
- Demonstration of a viable strategy for discovering ligands for cryptic binding sites.
Conclusions:
- The described protocol enables the engineering of proteins with accessible binding pockets, overcoming a key drug discovery barrier.
- This approach facilitates the identification of small-molecule ligands for cryptic targets, expanding therapeutic possibilities.
- The engineered protein variants serve as valuable tools for future drug screening and development efforts.

